Exane Derivatives’s BridgeBio Pharma BBIO Stock Holding History

Exane Derivatives’s Portfolio BBIO Stock Details BBIO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell
2021 Q4	$54.1K	Buy
2021 Q3	$105K	Sell
2021 Q2	$161K	Buy
2021 Q1	$101K	Buy
2020 Q4	$35.2K	Buy